Almac Wins Three CMO Leadership Awards

Almac Wins Three CMO Leadership Awards

March 23, 2016

Craigavon, N.I., UK, – 23 March 2016 We are pleased to announce that we have once again been selected as winners at this years’ CMO (Contract Manufacturing Organization) Leadership Awards for the fifth year.  The award was presented to VP of Commercial Operations, David Downey at an exclusive ceremony and reception in New York last week (16 March).

The awards are developed by Life Science Leader with the sole purpose of recognizing the industry’s top CMO’s.  The research was carried out by Industry Standard Research (ISReports.com) and based on their Contract Manufacturing Quality Benchmarking annual online survey.  More than 80 contract manufacturers were evaluated on 26 different performance metrics.

There are five CMO Leadership Award core categories: Quality, Reliability, Capabilities, Expertise, and Compatibility. Multiple performance metrics feed into each of these award categories to give added confidence to Almac.   Almac has emerged as the winner of three of these categories:

  • COMPATIBILITY  – Met customers’ expectations
  • QUALITY – Met customers’ expectations
  • RELIABILITY – Met customers’ expectations

David Downey, VP Commercial Operations commented:

We are pleased to have received yet another CMO Leadership Award for these three key categories. We pride ourselves on our ability to provide high quality, flexible and innovative solutions to meet our global clients’ requirements and these awards are recognition of our teams’ ongoing commitment to deliver just that.”

About Almac Group

‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organization that provides an extensive range of integrated services to over 600 companies globally within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organization that has organically grown over 40 years and now employs in excess of 4,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).

Almac Diagnostic Services is one of six business units operating under the ownership of the Almac Group.  The global company partners with the biopharmaceutical industry supporting the discovery, development and delivery of companion diagnostics. In addition, Almac Diagnostic Services has a pipeline of proprietary oncology based tests in development in therapeutic areas including breast, colon, ovarian, prostate and lung cancer.

For more information visit www.almacgroup.com or e-mail media@almacgroup.com.

Share

Back to news